Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-20
DOI
10.1038/s41375-018-0329-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma
- (2018) Enrico Caserta et al. BLOOD
- The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
- (2018) Leo Rasche et al. BLOOD
- Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
- (2018) Faith E. Davies et al. HAEMATOLOGICA
- Minimal residual disease in multiple myeloma: use of magnetic resonance imaging
- (2018) Jens Hillengass et al. SEMINARS IN HEMATOLOGY
- MRD Testing in Multiple Myeloma: The Main Future Driver for Modern Tailored Treatment
- (2018) Ola Landgren et al. SEMINARS IN HEMATOLOGY
- Functional Imaging Methods for Assessment of Minimal Residual Disease in Multiple Myeloma: Current Status and Novel ImmunoPET Based Methods
- (2018) Neeta Pandit-Taskar SEMINARS IN HEMATOLOGY
- Minimal Residual Disease Detection by Flow Cytometry in Multiple Myeloma: Why and How?
- (2018) Mikhail Roshal SEMINARS IN HEMATOLOGY
- Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
- (2018) Faith E. Davies et al. HAEMATOLOGICA
- The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
- (2017) Carolina Schinke et al. HAEMATOLOGICA
- Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
- (2017) Juan-Jose Lahuerta et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
- (2017) Philippe Moreau et al. JOURNAL OF CLINICAL ONCOLOGY
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
- (2017) J Flores-Montero et al. LEUKEMIA
- Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
- (2017) L. Rasche et al. Nature Communications
- 11C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
- (2017) Constantin Lapa et al. Theranostics
- The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
- (2017) Carolina Schinke et al. HAEMATOLOGICA
- Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
- (2017) Nikhil C. Munshi et al. JAMA Oncology
- Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
- (2016) B. Paiva et al. BLOOD
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- (2016) N. Weinhold et al. BLOOD
- Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition
- (2016) M. S. Raab et al. BLOOD
- Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis
- (2016) O Landgren et al. BONE MARROW TRANSPLANTATION
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma
- (2016) S Mithraprabhu et al. LEUKEMIA
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole-Body MR Imaging: Musculoskeletal Applications
- (2016) Frédéric E. Lecouvet RADIOLOGY
- Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
- (2016) J. G. Lohr et al. Science Translational Medicine
- Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications
- (2015) Xiaoyu Chen et al. BIOINFORMATICS
- PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
- (2015) E. Zamagni et al. CLINICAL CANCER RESEARCH
- Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
- (2015) C Pawlyn et al. LEUKEMIA
- Clinical value of molecular subtyping multiple myeloma using gene expression profiling
- (2015) N Weinhold et al. LEUKEMIA
- Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
- (2014) F. Favero et al. ANNALS OF ONCOLOGY
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Assessing the Relation Between Bone Marrow Signal Intensity and Apparent Diffusion Coefficient in Diffusion-Weighted MRI
- (2012) Anwar R. Padhani et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
- (2012) Christopher T. Saunders et al. BIOINFORMATICS
- Assessing response of myeloma bone disease with diffusion-weighted MRI
- (2012) C Messiou et al. BRITISH JOURNAL OF RADIOLOGY
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
- (2012) Pablo Cingolani et al. FLY
- Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data
- (2012) S. Waheed et al. HAEMATOLOGICA
- Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
- (2011) C. Messiou et al. EUROPEAN RADIOLOGY
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
- (2009) T. B. Bartel et al. BLOOD
- P53deletion may drive the clinical evolution and treatment response in multiple myeloma
- (2009) Lucía López-Anglada et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started